Study discovers link between a breakdown product from excess niacin and heart disease

Cleveland Clinic researchers have identified a new pathway that contributes to cardiovascular disease associated with high levels of niacin, a common B vitamin previously recommended to lower cholesterol.

Related Keywords

United States ,Stanley Hazen ,Jan Bleeksma ,Marc Ferrell ,Vascular Thoracic Institute ,National Institutes Of Health ,Human Health ,Cleveland Clinic Lerner Research Institute ,Cleveland Clinic Center ,Metabolic Sciences ,Cleveland Clinic ,Lerner Research Institute ,Co Section Head ,Preventive Cardiology ,Jan Bleeksma Chair ,Vascular Cell Biology ,Case Western Reserve University ,Medical Scientist Training Program ,National Institutes ,Heart ,Heart Disease ,Niacin ,Aging ,Atherosclerosis ,Flood ,Blood Vessels ,Ardiology ,Cardiovascular Disease ,Fell ,Cell Biology ,Cholesterol ,Hronic ,Iagnostic ,Diet ,Drugs ,Fruit ,Enetic ,Heart Attack ,Inflammation ,Inflammatory Disease ,Laboratory ,Medicine ,Etabolites ,Icrobiome ,Ortality ,Mh ,Reclinical ,Research ,Stroke ,Supplements ,Herapeutics ,Ascular ,Vegetables ,Vitamin B ,